Pharmaceutical Composition Comprising Glutarimide Derivatives And Use Thereof In The Treatment Of Eosinophilic Diseases

Abstract

The present invention relates to novel biologically active glutarimide derivatives of general formula (I) or a pharmaceutically acceptable salt thereof, their use as a therapeutic agent for the treatment of eosinophilic diseases, preferably of allergic nature, in particular bronchial asthma, allergic rhinitis, polypous rhinosinusopathies, eosinophilic colitis, eosinophilic syndrome, allergic conjunctivitis, atopic dermatitis, Churg-Strauss syndrome, anaphylactic shock, Quincke's edema, eosinophilic vasculitis, eosinophylic esophagitis, eosinophilic gastroenteritis, or fibroses. The invention also relates to pharmaceutical compositions comprising glutarimide derivatives of general formula (I):


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 24, 2018
  • Application: Nov 12, 2014
    US US 201415036603 A
  • Priority: Nov 12, 2014
    RU RU 2014000855 W
  • Priority: Nov 14, 2013
    RU RU 2013150861 A

Download Citation


Sign in to the Lens

Feedback